The accuracy of pharmacokinetic parameter measurement in DCE-MRI of the breast at 3 T

The purpose of this work is to quantify the accuracy of pharmacokinetic parameter measurement in DCE-MRI of breast cancer at 3 T in relation to three sources of error. Individually, T1 measurement error, temporal resolution and transmitted RF field inhomogeneity are considered. Dynamic contrast enhancement curves were simulated using standard acquisition parameters of a DCE-MRI protocol. Errors on pre-contrast T1 due to incorrect RF spoiling were considered. Flip angle errors were measured and introduced into the fitting routine, and temporal resolution was also varied. The error in fitted pharmacokinetic parameters, K(trans) and v(e), was calculated. Flip angles were found to be reduced by up to 55% of the expected value. The resultant errors in our range of K(trans) and v(e) were found to be up to 66% and 74%, respectively. Incorrect T1 estimation results in K(trans) and v(e) errors up to 531% and 233%, respectively. When the temporal resolution is reduced from 10 to 70 s K(trans) drops by up to 48%, while v(e) shows negligible variation. In combination, uncertainties in tissue T1 map and applied flip angle were shown to contribute to errors of up to 88% in K(trans) and 73% in v(e). These results demonstrate the importance of high temporal resolution, accurate T1 measurement and good B1 homogeneity.

[1]  P S Tofts,et al.  Quantitative Analysis of Dynamic Gd‐DTPA Enhancement in Breast Tumors Using a Permeability Model , 1995, Magnetic resonance in medicine.

[2]  T W Redpath,et al.  Accuracy of T1 measurement in dynamic contrast‐enhanced breast MRI using two‐ and three‐dimensional variable flip angle fast low‐angle shot , 1999, Journal of magnetic resonance imaging : JMRI.

[3]  A. Padhani,et al.  Assessing changes in tumour vascular function using dynamic contrast‐enhanced magnetic resonance imaging , 2002, NMR in biomedicine.

[4]  P. Tofts.  Modeling tracer kinetics in dynamic Gd‐DTPA MR imaging , 1997, Journal of magnetic resonance imaging : JMRI.

[5]  Thomas E Yankeelov,et al.  Temporal sampling requirements for reference region modeling of DCE‐MRI data in human breast cancer , 2009, Journal of magnetic resonance imaging : JMRI.

[6]  M. Viergever,et al.  Measuring the arterial input function with gradient echo sequences , 2003, Magnetic resonance in medicine.

[7]  D Krebs,et al.  Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results. , 2000, Radiology.

[8]  Vasily L Yarnykh,et al.  Actual flip‐angle imaging in the pulsed steady state: A method for rapid three‐dimensional mapping of the transmitted radiofrequency field , 2007, Magnetic resonance in medicine.

[9]  Min-Ying Su,et al.  Breast Cancer Patients Undergoing Neoadjuvant AC-Chemotherapy , 2008 .

[10]  H. Weinmann,et al.  Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers. , 1984, Physiological chemistry and physics and medical NMR.

[11]  Hans H Schild,et al.  Effect of B1 inhomogeneity on breast MR imaging at 3.0 T. , 2007, Radiology.

[12]  U. Fischer,et al.  International investigation of breast MRI: results of a multicentre study (11 sites) concerning diagnostic parameters for contrast-enhanced MRI based on 519 histopathologically correlated lesions , 2001, European Radiology.

[13]  Eri Shibata,et al.  Enhancement effects and relaxivities of gadolinium-DTPA at 1.5 versus 3 Tesla: a phantom study. , 2005, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.

[14]  Huanzhou Yu,et al.  Relaxation times of breast tissue at 1.5T and 3T measured using IDEAL , 2006, Journal of magnetic resonance imaging : JMRI.

[15]  P. Tofts,et al.  Measurement of the blood‐brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts , 1991, Magnetic resonance in medicine.

[16]  R. Lucht,et al.  Microcirculation and microvasculature in breast tumors: Pharmacokinetic analysis of dynamic MR image series , 2004, Magnetic resonance in medicine.

[17]  T W Redpath,et al.  Baseline MRI delivery characteristics predict change in invasive ductal breast carcinoma PET metabolism as a result of primary chemotherapy administration. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[18]  T W Redpath,et al.  The effects of renal variation upon measurements of perfusion and leakage volume in breast tumours. , 2004, Physics in medicine and biology.

[19]  L. Turnbull,et al.  Role of dynamic contrast enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy , 2005, Breast Cancer Research and Treatment.

[20]  Christian Hintze,et al.  Combination of low and high resolution sequences in two orientations for dynamic contrast-enhanced MRI of the breast: more than a compromise , 2004, European Radiology.

[21]  A. Elster.  Artifacts in 3-T MRI: Physical background and reduction strategies , 2009 .

[22]  B K Rutt,et al.  Temporal sampling requirements for the tracer kinetics modeling of breast disease. , 1998, Magnetic resonance imaging.

[23]  Ying Lu,et al.  Kinetic assessment of breast tumors using high spatial resolution signal enhancement ratio (SER) imaging , 2007, Magnetic resonance in medicine.

[24]  Natal A W van Riel,et al.  On the identifiability of pharmacokinetic parameters in dynamic contrast‐enhanced imaging , 2007, Magnetic resonance in medicine.

[25]  Glyn Johnson,et al.  Measuring blood volume and vascular transfer constant from dynamic, T  2* ‐weighted contrast‐enhanced MRI , 2004, Magnetic resonance in medicine.

[26]  R. Deichmann,et al.  Influence of RF spoiling on the stability and accuracy of T1 mapping based on spoiled FLASH with varying flip angles , 2009, Magnetic resonance in medicine.

[27]  A. Padhani,et al.  Non‐invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer , 2001, The British journal of surgery.

[28]  Farin Kamangar,et al.  Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.